Drug Evaluation Committee Video Distribution - GCP has moved from a checklist to a "thinking" guideline. Now is the time to become a self-directed thinker! -Exploring the key to mindset through trends and specific examples of Clinical Trial 119
Aug 06, 2025
KT-3, Clinical Evaluation Subcommittee, Committee on Drug Evaluation, Japan Pharmaceutical Manufacturers Association (JPMA), will hold a symposium entitled "GCP has moved from a checklist to a guideline for 'how to think'. Now is the time to become a thinker! ～The purpose of the video is to emphasize the need for each clinical trial site to embody the "Way of Thinking" that is emphasized in the GCP Renovation. The video is aimed at all those who are involved in clinical trials.
The video is aimed at all personnel involved in clinical trials, and is intended to highlight the limitations and risks of problem solving that relies on precedent and others, and the need for behavioral change in problem solving based on these limitations and risks.
The recording of this symposium can be viewed at the following link.
Please fill out the questionnaire after watching the program.
https://survey.sogolytics.com/r/KdUWIH
Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation, Clinical Evaluation Subcommittee KT-3